esmolol has been researched along with metoprolol in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Akhtar, M; Avitall, B; Jazayeri, MR; Murthy, VS; Shen, YH; Sra, JS; Troup, PJ | 1 |
| Deegan, R; Wood, AJ | 1 |
| Akhtar, M; Dhala, A; Natale, A; Newby, KH; Sra, J | 1 |
| Alhashemi, JA; Hooper, J | 1 |
| Hauptman, PJ; Prirzker, MR; Woods, D | 1 |
| Berry, C; Corbett, W; Fleisher, LA; Poldermans, D | 1 |
| Hobai, IA | 1 |
| Mizogami, M; Takakura, K; Tsuchiya, H | 1 |
| Bakker, EJ; Chonchol, M; Hoeks, SE; Klimek, M; Poldermans, D; Ravensbergen, NJ; Voute, MT | 1 |
| Guo, Q; Wang, L; Yang, G; Yang, J | 1 |
| Freundlich, RE; Kheterpal, S; Mashour, GA; Matlen, L; Merte, J; Nallamothu, BK; Shanks, A; Sharifpour, M; Tremper, KK; Vlisides, PE; Weightman, A | 1 |
| Foex, P; Morelli, A; Sanfilippo, F; Santonocito, C | 1 |
| Gu, X; Lu, Y; Wang, G; Wang, H; Wang, Y; Yan, C | 1 |
| Aguiar Rosa, S; Casado, H; Cruz Ferreira, R; Figueiredo, L; Leal, C; Marques, H; Ramos, R; Santos, R; Saraiva, M | 1 |
| Brubaker, S; Koyfman, A; Long, B | 1 |
| Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
| Franz, AR; Gruendler, K; Lorenz, L; Poets, CF; Schwarz, CE | 1 |
| Chen, C; Ding, W; Du, Y; Ma, X; Sun, X; Tao, Y | 1 |
| Eifer, DA; Karimzad, Y; Paul, NS; Vimala, LR | 1 |
4 review(s) available for esmolol and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Beta-blocker use in severe sepsis and septic shock: a systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Heart Rate; Hemodynamics; Humans; Metoprolol; Propanolamines; Sepsis; Shock, Septic | 2015 |
Alternative Treatment Options for Atrioventricular-Nodal-Reentry Tachycardia: An Emergency Medicine Review.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; Electric Countershock; Electrocardiography; Emergency Medicine; Emergency Service, Hospital; Female; Humans; Male; Metoprolol; Propanolamines; Propranolol; Review Literature as Topic; Tachycardia, Atrioventricular Nodal Reentry; Vagus Nerve Stimulation; Verapamil | 2018 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
3 trial(s) available for esmolol and metoprolol
| Article | Year |
|---|---|
Beta-receptor antagonism does not fully explain esmolol-induced hypotension.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Blood Pressure; Dose-Response Relationship, Drug; Exercise; Humans; Infusions, Intravenous; Male; Metoprolol; Norepinephrine; Propanolamines; Propranolol | 1994 |
A randomised study of perioperative esmolol infusion for haemodynamic stability during major vascular surgery; rationale and design of DECREASE-XIII.
Topics: Adrenergic beta-Antagonists; Adult; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Ischemia; Metoprolol; Perioperative Period; Propanolamines; Research Design; Vascular Surgical Procedures | 2011 |
Topics: Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Cost-Benefit Analysis; Female; Heart Rate; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Prospective Studies; Single-Blind Method | 2022 |
21 other study(ies) available for esmolol and metoprolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Female; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Metoprolol; Posture; Predictive Value of Tests; Propanolamines; Syncope | 1992 |
Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Isoproterenol; Male; Metoprolol; Middle Aged; Posture; Propanolamines; Recurrence; Syncope, Vasovagal; Treatment Outcome | 1996 |
Treatment of milrinone-associated tachycardia with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Epidural; Anesthesia, General; Anti-Arrhythmia Agents; Aortic Aneurysm, Abdominal; Arrhythmia, Sinus; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Elective Surgical Procedures; Ethanol; Heart Rate; Humans; Hypertension; Hypotension; Male; Metoprolol; Milrinone; Myocardial Ischemia; Propanolamines; Pulmonary Artery; Pyridones; Tachycardia | 1998 |
Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Infusions, Intravenous; Metoprolol; Milrinone; Propanolamines; Treatment Outcome | 2002 |
Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Atenolol; Bisoprolol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Infusions, Intravenous; Metoprolol; Perioperative Care; Postoperative Complications; Propanolamines; Treatment Outcome; Vascular Surgical Procedures | 2004 |
Atrioventricular block induced by indigo carmine.
Topics: Adjuvants, Anesthesia; Adrenergic Agents; Adrenergic beta-Antagonists; Anesthetics, Intravenous; Atrioventricular Block; Blood Pressure; Coloring Agents; Cystoscopy; Electrocardiography; Ephedrine; Female; Heart Rate; Humans; Indigo Carmine; Intraoperative Complications; Male; Metoprolol; Midazolam; Middle Aged; Muscarinic Antagonists; Propanolamines; Propofol; Prostatectomy | 2008 |
The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia; Anesthetics; Atenolol; Biomimetics; Lipid Bilayers; Lipids; Liposomes; Membranes, Artificial; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2010 |
[Chiral separation of five beta-blockers using di-n-hexyl L-tartrate-boric acid complex as mobile phase additive by reversed-phase liquid chromatography].
Topics: Adrenergic beta-Antagonists; Boric Acids; Chromatography, Reverse-Phase; Dicarboxylic Acids; Metoprolol; Propanolamines; Propranolol; Stereoisomerism; Sugar Acids | 2012 |
Perioperative metoprolol and risk of stroke after noncardiac surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Atenolol; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Incidence; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Monitoring, Intraoperative; Odds Ratio; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Young Adult | 2013 |
[Preparation of 1 µm non-porous C18 silica gel stationary phase for chiral-pressurized capillary electrochromatography].
Topics: beta-Cyclodextrins; Bupropion; Capillary Electrochromatography; Chromatography, Liquid; Clenbuterol; Metoprolol; Propanolamines; Silanes; Silica Gel; Silicon Dioxide | 2015 |
Bailout intravenous esmolol for heart rate control in cardiac computed tomography angiography.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Coronary Angiography; Female; Heart Rate; Humans; Injections, Intravenous; Male; Metoprolol; Multidetector Computed Tomography; Propanolamines; Salvage Therapy; Treatment Failure | 2016 |
Beta blocker therapy in recipients of twin-to-twin transfusion syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Cardiac Output, Low; Echocardiography; Female; Fetofetal Transfusion; Humans; Hypotension; Infant, Newborn; Metoprolol; Pregnancy; Propanolamines; Tachycardia; Treatment Outcome; Ventricular Function; Ventricular Outflow Obstruction | 2019 |
Metal organic framework HKUST-1 modified with carboxymethyl-β-cyclodextrin for use in improved open tubular capillary electrochromatographic enantioseparation of five basic drugs.
Topics: Amlodipine; beta-Cyclodextrins; Capillary Electrochromatography; Metal-Organic Frameworks; Metoprolol; Propanolamines; Propranolol; Sotalol; Stereoisomerism | 2019 |